CAR Treg-cell therapy (TxCell/Ospedale San Raffaele)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameCAR Treg-cell therapy (TxCell/Ospedale San Raffaele)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocytes inhibitorsT lymphocytes stimulantsImmunosuppressants

TargetsUpdating

Therapy Area/IndicationsLupus Nephritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItalyFrance

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSangamo Therapeutics France Sas

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSangamo Therapeutics France Sas Ospedale San Raffaele

Active IndicationsN/A

Inactive IndicationsLupus Nephritis

Other Information

ATC CodeN/A